Skip to main content
SpringerLink
Log in

Therapie von Insomnien

  • Conference paper
Schlaf, Gesundheit, Leistungsfähigkeit

Zusammenfassung

Insomnien entstehen aus einem Mißverhältnis zwischen Schlafbedürfnis und Schlafvermögen. Sie stellen einen Mangel an Schlafqualität oder Schlafquantität dar. Sie sind auch ein subjektives Phänomen und damit die individuelle Wahrnehmung eines gestörten Schlafs (ASDC 1979; Soldatos et al. 1979; Kales u. Kales 1984; Parkes 1985; APA 1987; ASDA 1990; Buysse u. Reynolds 1990).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adam K, Oswald I (1989) Can a rapidly-eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 22:115–119

    Article  PubMed  CAS  Google Scholar 

  • Agnoli A, Manna V, Martucci N (1989) Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Clin Pharmacol Res 10(4):277–281

    Google Scholar 

  • Albin H, Vincon G, Vincon J, Hermann P, Thiercelin JF (1988) Study of pharmacokinetics of Zolpidem in healthy volunteers after repeated administration: effect on antipyrine clearance. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 369–370

    Google Scholar 

  • Allain H, Delahaye Ch, Le Coz F et al. (1991) Post-marketing surveillance of zopiclone in insomnia: analysis of 20,513 cases. Sleep 14(5):408–413

    PubMed  CAS  Google Scholar 

  • Anderson AA (1985) Zopiclone and nitrazepam: a multicentre placebo controlled comparative study of efficacy and tolerance in insomniac patients in general practice. In: 1st Int Conf Recent advances in drug treatment in psychiatry, Montreaux, Oct 6–11

    Google Scholar 

  • Anton-Tay F (1974) Melatonin: effects on brain function. Adv Biochem Psychopharmacol 11:315–324

    PubMed  CAS  Google Scholar 

  • APA — American Psychiatric Association (ed) (1987) Diagnostisches und statistisches Manual psychischer Störungen (DSM-III-R). Dtsch Bearbeitung und Einführung von Wittchen H-U, Saß H, Zaudig M, Köhler K. Beltz, Weinheim

    Google Scholar 

  • Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (1985) Spät-dyskinesien nach Neuroleptikagabe. Dtsch Ärztebl 23:1787

    Google Scholar 

  • Arendt J (1985) Mammalian pineal rhythms. Pineal Res Rev 3:161–213

    CAS  Google Scholar 

  • Arendt J, Aldhous M, Marks V (1986) Alleviation of jet leg by melatonin: preliminary results of controlled double blind trial. Br Med J 292:1170

    Article  CAS  Google Scholar 

  • Ascher LM, Turner RM (1979) Paradoxical intention and insomnia: an experimental investigation. Behav Res Ther 17:408–411

    Article  PubMed  CAS  Google Scholar 

  • ASDA — American Sleep Disorders Association (1990) The international classification of sleep disorders: diagnostic and coding manual. Allen, Lawrence

    Google Scholar 

  • ASDC — Association of Sleep Disorders Centers (1979) Diagnostic classification of sleep and arousal disorders. Sleep 2:1–137

    Google Scholar 

  • Autret E, Maillard F, Autret A (1987) Comparison of the clinical hypnotic effects of zopiclone and triazolam. Eur J Clin Pharmacol 31:621–623

    Article  PubMed  CAS  Google Scholar 

  • Balderer G, Borbely AA (1985) Effect of valerian on human sleep. Psychopharmacology 87:406–409

    Article  PubMed  CAS  Google Scholar 

  • Beckmann H (1985) Behandlung von Schlafstörungen in der Praxis. Therapiewoche 35:5542–5552

    Google Scholar 

  • Beckmann H, Hippius H (1976) Gebrauch und Mißbrauch von Schlafmitteln aus der Sicht des Psychiaters. Internist 17(5):245–252

    PubMed  CAS  Google Scholar 

  • Benkert O, Hippius H (1986) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bensimon G, Warot D, Foret J, Thiercelin JF, Barthelet G, Simon P (1988) Residual effects of hypnotics: comparative study of Zolpidem and flunitrazepam versus placebo. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, p 374

    Google Scholar 

  • Besset A et al. (1989) Effect of Zolpidem on waking and sleeping in the poor sleeper. Polygraphic and psychometric study. In: Insomnie et imidazopyridines, Symposium international Paris 27. April 1989: Excerpta Medica: 231–232, 286–287

    Google Scholar 

  • Betts TA, Birtle J (1982) Effects of two hypnotic drugs on actual driving performance next morning. Br Med J 285:852

    Article  CAS  Google Scholar 

  • Berlin RM (1985) Psychotherapeutic treatment of chronic insomnia. Am J Psychother 39(1):68–74

    PubMed  CAS  Google Scholar 

  • Berman TM, Nino-Murcia G, Roehrs T (1990) Sleep disorders. Take them seriously. Patient Care 23:85–113

    Google Scholar 

  • Berti LA, Hoffmann SO (1990) Psychogene und Psychoreaktive Störungen des Schlafes. Vorkommen, Typen, Ursachen und Therapie. Nervenarzt 61(1):16–27

    PubMed  CAS  Google Scholar 

  • Beutler LE, Thornby JI, Karacan I (1974) Psychological variables in the diagnosis of insomnia. In: Williams RL, Karacan I (eds) Sleep disorders: diagnosis and treatment. John Wiley & Sons, New York, pp 61–100

    Google Scholar 

  • Bianchetti G, Dubruc C, Thiercelin JF, Bercoff E, Bouchet JL, Emeriau JP, Galperine I, Lambert D, Vandel B, Thebault JJ (1988) Clinical pharmacokinetics of Zolpidem in various physiological and pathological conditions. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 155–163

    Google Scholar 

  • Billiard M, Besset A, De Lustrac C, Brissaud L (1983) Dose-response effects of zopiclone on night sleep and on night-time and daytime functioning. In: 4th Int Congr Sleep research (APSS), Bologna, July 18–22

    Google Scholar 

  • Binnie GA (1983) Psychotropic drugs and accidents in general practice. Br Med J 287:1349–1350

    Article  CAS  Google Scholar 

  • Bixler EO, Kales A, Leo LA, Slye EC (1973) A comparison of subjective estimates and objective sleep laboratory findings in insomniac patients. Sleep Res 2:143

    Google Scholar 

  • Bixler EO, Kales J, Kales A et al. (1985) Rebound insomnia and elimination half-life: assessment of individual subject response. J Clin Pharmacol 25(2): 115–124

    PubMed  CAS  Google Scholar 

  • Bliwise DL, Seidel WF, Cohen SA et al. (1987) Profile of mood states (POMS) changes during long term use of triazolam. Sleep Res 16:77

    Google Scholar 

  • Böning J (1982) Zentralmotorische und extrapyramidale Nebenwirkungen unter Therapie mit Antidepressiva. Fortschr Neurol Psychiat 50:35–47

    Article  PubMed  Google Scholar 

  • Bootzin RR (1972) A stimulus control treatment for insomnia. In: Proc Am Psychol Assoc, Honu-lulu, Hawaii, Sept 1–9, pp-395–396

    Google Scholar 

  • Bootzin RR, Nicassio PM (1978) Behavioral treatments for insomnia. Prog Behav Med 6:1–45

    Google Scholar 

  • Bootzin RR, Engle-Friedman M, Hazelwood L (1983) Insomnia. In: Lewinsohn PM, Teri L (eds) Clinical geropsychology: new directions in assessment and treatment. Pergamon, New York, pp 81–115

    Google Scholar 

  • Borbély AA (1984 a) Schlafgewohnheiten, Schlafqualität und Schlafmittelkonsum der Schweizer Bevölkerung. Ergebnisse einer Repräsentativumfrage. Schweiz Ärztez 34:1606–1613

    Google Scholar 

  • Borbély AA (1984 b) Das Geheimnis des Schlafs. DTV, München

    Google Scholar 

  • Borbély AA (1986 a) Schlafmittel und Schlaf. Übersicht und therapeutische Richtlinien. Ther Umsch 43:509–516

    PubMed  Google Scholar 

  • Borbély AA (1986 b) Benzodiazepinhypnotika: Wirkungen und Nachwirkungen von Einzeldosen. In: Hippius H, Engel RR, Laakmann G (Hrsg) Benzodiazepine. Rückblick und Ausblick. Springer, Berlin Heidelberg New York, S 96–100

    Google Scholar 

  • Borbély AA, Tobler I (1989) Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 69:605–670

    PubMed  Google Scholar 

  • Borbély AA, Loepfe M, Mattmann P, Tobler I (1983) Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Arzneim Forsch Drug Res 33:1500–1502

    Google Scholar 

  • Borkovec TD (1982) Insomnia. J Consult Clin Psychol 50:880–895

    Article  PubMed  CAS  Google Scholar 

  • Brainard GC, Lewy AJ, Menaker M et al. (1988) Dose-response relationship between light irri-dance and the suppression of plasma melatonin in human volunteers. Brain Res 454:212–218

    Article  PubMed  CAS  Google Scholar 

  • Buysse DJ, Reynolds CF (1990) Insomnia: In: Thorpy MJ (ed) Handbook of sleep disorders. Dekker, New York Basel, pp 375–433

    Google Scholar 

  • Byerley B, Gillin JC (1984) Diagnosis and management of insomnia. Psychiatr Clin N Am 7:773–789

    CAS  Google Scholar 

  • Carman JS, Post RM, Buswell R, Goodwin FK (1976) Negative effects of melatonin on depression. Am J Psychiat 133:1181–1186

    PubMed  CAS  Google Scholar 

  • Carskadon MA, Dement WC, Mitler MM et al. (1976) Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiat 133:1382–1388

    PubMed  CAS  Google Scholar 

  • Carskadon MA, Brown E, Dement WC (1982) Sleep fragmentation in the elderly: relationship to daytime sleep tendency. Neurobiol Aging 3:321–327

    Article  PubMed  CAS  Google Scholar 

  • Chan AW (1984) Effects of combined alcohol and benzodiazepine: a review. Drug Alcohol Depend: 315–341

    Google Scholar 

  • Chouinard G (1985) A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiat 46:32–37

    CAS  Google Scholar 

  • Cirignotta F, Mondini S, Zucconi M et al. (1985) Insomma: an epidemiological survey. Clin Neu-ropharmacol 8 Suppl 1:49–54

    Google Scholar 

  • Clarenbach C, Birmanns B, Krätzschmar S, Jaursch-Haucke (1986) Sleep pattern and nocturnal plasma profiles of HGH, prolactin, Cortisol in man after the serotonin-antagonist ritanserin and the GABA-antagonist gabapentin. Sleep Res 15:29

    Google Scholar 

  • Cleghorn JM, Bellissimo A, Kaplan RD, Szatmari P (1983) Insomnia. II. Assessment and treatment of chronic insomnia. Can J Psychiat 28(5):347–353

    CAS  Google Scholar 

  • Coleman RM (1983) Diagnosis, treatment and follow-up of about 8,000 sleep/wake disorders patients. In: Guilleminault C, Lugaresi E (eds) Sleep/wake disorders. Reven, New York, pp 87–98

    Google Scholar 

  • CRM — Committee on the Review of Medicines (ed) (1980) Systemic review of the benzodiazepines. Br J Med 280:910–912

    Google Scholar 

  • Cordingly GJ, Dean BC, Harris RI (1984) A double-blind comparison of two benzodiazepine hypnotics, flunitrazepam and triazolam, in general practice. Curr Med Res Opin 8:714–719

    Article  Google Scholar 

  • Danek A, Pollmächter TH (1990) Restless-legs syndrome. Klinik, Differentialdiagnose, Therapieansätze. Nervenarzt 61(2):69–76

    PubMed  CAS  Google Scholar 

  • Degkwitz R, Helmchen H, Kochott G, Mombour W (1979) Diagnoseschlüssel und Glossar psychiatrischer Krankheiten. Korrigiert nach der 9. Revision der ICD (= International Classification of Diseases). Springer, Berlin Heidelberg New York

    Google Scholar 

  • Dehlin O, Rundgren Ä, Börjesson L et al. (1983) Zopiclone to geriatric patients. Pharmacology 27:173–178

    Article  PubMed  Google Scholar 

  • Dement WC (1983) Rational basis for the use of sleeping pills. Pharmacol 27, Suppl 2:3–38

    Article  Google Scholar 

  • Dement WC, Seidel W, Carskadon MA (1984) Issues in the diagnosis and treatment of insomnia. Psychopharmacol Suppl 1:11–43

    Google Scholar 

  • Dettli L (1983) Benzodiazepines in the treatment of insomnia: pharmacokinetic considerations. In: Costa E (ed) The benzodiazepines: from molecular biology to clinical practice. Raven, New York, pp 201–223

    Google Scholar 

  • Dijk DJ, Beersma DGM, Daan S, van den Hoofdakker RH (1989) Effects of Seganserin on 5 HT 2-antagonist and Temazepam on human sleep stages and EEG power-spectra. Eur J Pharmacol 171:207–218

    Article  PubMed  CAS  Google Scholar 

  • Dilling H (1985) Schlafstörungen aus psychiatrischer Sicht. Therapiewoche 35:1713–1722

    Google Scholar 

  • Dilling H, Weyerer S (1978) Epidemiologie psychischer Störungen und psychiatrische Versorgung. Urban & Schwarzenberg, München Wien Baltimore

    Google Scholar 

  • Dolly FR, Block AJ (1982) Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73:239–243

    Article  PubMed  CAS  Google Scholar 

  • Dorow R, Berenberg D (1990) Benzodiazepine und Amnesie. In: Rudolph GA, Engfer A (Hrsg) Schlafstörungen in der Praxis. Diagnostische und therapeutische Aspekte. Vieweg, Braunschweig Wiesbaden, S 82–102

    Google Scholar 

  • Drucker-Colin RR (1981) Endogenous sleep peptides. In: Wheathley D (ed) Psychopharmacology of sleep. Raven, New York, pp 53–72

    Google Scholar 

  • Dube S, Jones DA, Bell J et al. (1986) Interface of panic and depression: clinical and sleep EEG correlates. Psychiat Res 19(2): 119–133

    Article  CAS  Google Scholar 

  • Duriez R, Barthelemy C, Rives H et al. (1979) Traitment des troubles du sommeil par la zopiclone. Thérapie 34:317–325

    PubMed  CAS  Google Scholar 

  • Editorial to Lancet (1990) Zopiclone: another carriage on the tranquillizer train. Lancet 335:507–508

    Article  Google Scholar 

  • Elie R, Gagnon MA (1981) Hypnotic properties of zopiclone. In: Abstr 1299, 8th Int Congr Pharmacology, Tokyo

    Google Scholar 

  • Elie R, Frenay M, Le Morvan P, Bourgouin J (1990) Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. Int Clin Psychopharmacol 5:39–46

    Article  PubMed  Google Scholar 

  • Engel R, Engel-Sittenfeld P (1980) Schlafverhalten, Persönlichkeit und Schlafmittelgebrauch von Patienten mit chronischen Schlafstörungen. Nervenarzt 51:22–29

    PubMed  CAS  Google Scholar 

  • Engel RR, Knab B (1985) Theoretische Vorstellungen zur Genese von Schlafstörungen. In: Vaiti D, Knapp TW, Birbaumer N (Hrsg) Psychophysiologische Merkmale klinischer Symptome, Bd 1: Psychophysiologische Dysfunktionen. Beltz, Weinheim Basel, S 128–142

    Google Scholar 

  • Espie CA, Lindsay WR (1985) Paradoxical intention in the treatment of chronic insomnia: six case studies illustrating variability in therapeutic response. Behav Res Ther 23(6):703–709

    Article  PubMed  CAS  Google Scholar 

  • Faust V, Hole G (1980) Der gestörte Schlaf (I). Zur Diagnose der Schlafstörungen. Z Allgemeinmed 35/36:2423–2436

    Google Scholar 

  • Feighner JP, Cohn JB (1985) Double-blind comparative trials of Fluoxetine and Doxepine in geriatric patients with major depression. J Clin Psychiat 46:20–25

    CAS  Google Scholar 

  • Finke J (1976) Neuroleptika bei Schlafstörungen. Therapiewoche 26:3818–3826

    Google Scholar 

  • Finke J, Schulte W (1979) Schlafstörungen. Thieme, Stuttgart

    Google Scholar 

  • Fleming JAE, Bourgouin J, Hamilton P (1988) A sleep laboratory evaluation of the long-term efficacy of zopiclone. Can J Psychiat 33:103–107

    CAS  Google Scholar 

  • Fleming JA, McClure DJ, Mayes C et al. (1990) A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. Int Clin Psychopharmacol 5(2):29–33

    PubMed  Google Scholar 

  • Fogle DO, Dyal JA (1978) Paradoxical giving up and the reduction of sleep performance and anxiety in chronic insomniacs. Psychother Theor Res Pract 20:21–30

    Article  Google Scholar 

  • Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262:1479–1484

    Article  PubMed  CAS  Google Scholar 

  • Forth W (1989) Pharmaka zur Therapie von Schlafstörungen. In: Hippius H, Lauter H, Greil W (Hrsg) Psychiatrie für die Praxis 10. Der gestörte Schlaf. MMV, München, S 45–49

    Google Scholar 

  • Frankel BL, Coursey RD, Buchbinder R, Snyder F (1976) Recorded and reported sleep in chronic primary insomniacs. Arch Gen Psychiat 33:615–623

    Article  PubMed  CAS  Google Scholar 

  • Frattola L et al. (1990) Double blind comparison of Zolpidem 20 mg versus Flunitrazepam 2 mg in insomniac in-patients. Drugs Exptl Clin Res XVI(7):371–376

    Google Scholar 

  • Friedman H, Greenblatt DJ (1985) The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection. J Clin Pharmacol 25:448–451

    PubMed  CAS  Google Scholar 

  • Gaillot J, Heusse D, Houghton G et al. (1983) Pharmacokinetics and metabolism of zopiclone. Pharmacology 27:76–91

    Article  PubMed  CAS  Google Scholar 

  • Ganguli R, Reynolds CF, Kupfer DJ (1987) Electroencephalographic sleep in young, never-medicated schizophrenics: a comparison with delusional and nondelusional depressives and with healthy controls. Arch Gen Psychiat 44:36–44

    Article  PubMed  CAS  Google Scholar 

  • George CFP, Millar TW, Hanley PJ, Kryger MH (1989) The effect of L-Tryptophan on daytime sleep latency in normals: correlation with blood levels. Sleep 12(4):345–353

    PubMed  CAS  Google Scholar 

  • Gillin JC; Byerley WF (1990) Drug-therapy: the diagnosis and management of insomnia. N Engl J Med 322:239–248

    Article  PubMed  CAS  Google Scholar 

  • Gillin JC, Sitaram N, Wehr T et al. (1984) Sleep and affective illness. In: Post R, Ballenger J (eds) Neurobiology of mood disorders. Williams & Wilkins, Baltimore, pp 157–189

    Google Scholar 

  • Giercksky K-F, Wickström E (1980) A dose-response study in situational insomnia with zopiclone, a new tranquilizer. Clin Therap 3:21–27

    CAS  Google Scholar 

  • Gnirrs F, Schneider-Helmert D, Schenker J, Winkler V (1978) Schlafstörungen bei psychisch Kranken. Nervenarzt 49:394–401

    Google Scholar 

  • Goldfried MR, Davison GC (1979) Klinische Verhaltenstherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Greenblatt D, Allen M (1979) Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 5:407–413

    Google Scholar 

  • Greenblatt D, Divoll M, Harmatz J et al. (1981) Kinetic and clinical effects of flurazepam in young and old noninsomniacs. Clin Pharmacol Ther 30:475–486

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt D, Divoll M, Abemethy D, Shader R (1982) Benzodiazepine hypnotics: kinetic and therapeutic option. Sleep 5:18–21

    Google Scholar 

  • Grossmann W (1979) Schlaf und Pharmakon. Pharmakotherapie 2:214–222

    Google Scholar 

  • Guilleminault C (1989) Clinical features and evaluation of obstructive sleep apnea. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 552–558

    Google Scholar 

  • Hajak G, Rüther E (1991 a) Chronic insomnia in the elderly. In: Racagni G, Brunello N, Fukendo T (eds) Biological psychiatry, vol 1. Elsevier, Amsterdam, pp 845–848

    Google Scholar 

  • Hajak G, Rüther E (1991 b) Chronische Insomnien — ein diagnostisches und therapeutisches Problemfeld. In: Steinberg R (Hrsg) Schlaf. Tilia, Klingenmünster, S 60–64

    Google Scholar 

  • Hajak G, Rüther E (1992) Schlafstörungen — ein dringliches Gesundheitsproblem. In: Schulz H, Engfer A (Hrsg) Schlafmedizin heute. Diagnostische und therapeutische Empfehlungen. MMV, München, S 14–34

    Google Scholar 

  • Hajak G, Hüther G, Blanke J et al. (1991) The influence of intravenous L-Tryptophan on plasma melatonin and sleep in men. Pharmacopsychiatry 24:17–20

    Article  PubMed  CAS  Google Scholar 

  • Hajak G, Rüther E, Hauri PJ (1992) Insomnien. In: Berger M (Hrsg) Handbuch des normalen und gestörten Schlafs. Springer, Berlin Heidelberg New York, S 67–119

    Chapter  Google Scholar 

  • Hartmann E, Cravens J (1973) The effects of long-term administration of psychotropic drugs on human sleep: III. The effects of amitriptyline. Psychopharmacoloy 33:185–202

    Article  CAS  Google Scholar 

  • Hartmann E, Greenwald D (1984) Tryptophan and human sleep: an analysis of 43 studies. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progressive tryptophan and serotonin research. DeGruyter, Berlin New York, pp 297–304

    Google Scholar 

  • Hartmann E, Lindsley JG, Spinweber C (1983) Chronic insomnia: effects of tryptophan, fluraze-pam, secobarbital and placebo. Psychopharmacology 80:138–142

    Article  PubMed  CAS  Google Scholar 

  • Harvengt C, Hulhoven R, Desager JP, Coupez JM, Guillet Ph, Fuseau E, Lambert D, Warrington SJ (1988) Drug interactions investigated with Zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 165–173

    Google Scholar 

  • Hauri PJ (1989a) Primary insomnia. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 442–447

    Google Scholar 

  • Hauri PJ (1989b) Verhaltenstherapie bei Schlafstörungen. In: Meier-Ewert K, Schulz H (Hrsg) Schlaf und Schlafstörungen. Springer, Berlin Heidelberg New York, S 147–155

    Google Scholar 

  • Hauri PJ, Olmstead E (1980) Childhood-onset insomnia. Sleep 3:59–66

    PubMed  CAS  Google Scholar 

  • Hauri PJ, Orr WC (1982) Current concepts: the sleep disorders. Upjohn, Kalamazoo

    Google Scholar 

  • Hauri PJ, Friedman M, Ravaris CL (1989) Sleep in patients with spontaneous panic attacks. Sleep 12(4):323–337

    PubMed  CAS  Google Scholar 

  • Hayaishi D (1988) Sleep wake regulation by prostaglandins. D2 and E2. J Biol Chem 263:14593–14596

    PubMed  CAS  Google Scholar 

  • Hermann-Maurer EK, Schneider-Helmert D, Zimmermann A, Schönberger GA (1990) Diagnostisches Inventar nach DSM-III bei Patienten mit schweren Schlafstörungen. Nervenarzt 61(1):28–33

    PubMed  CAS  Google Scholar 

  • Herrmann WM, Kubicki St, Wober W (1988) Zolpidem: a four-week pilot Polysomnographic study in patients with chronic sleep disturbances. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 261–278

    Google Scholar 

  • Hindmarch I (1990) Immediate and overnight effects of zopiclone 7,5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers. Int Clin Psychopharmacol 5(2): 105–143

    PubMed  Google Scholar 

  • Hindmarch J, Ott H, Roth T (1984) Sleep benzodiazepines and performance. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Hippius H, Rüther E (1977) Klinik und Therapie von Störungen der Schlaf-Wach-Funktion. Verh Dtsch Ges Inn Med 83:913–928

    PubMed  CAS  Google Scholar 

  • Hoffmann SO (1980) Psychodynamik und Therapie von Schlafstörungen. Intern Prax 20:495–500

    Google Scholar 

  • Horne JA, Reid AJ (1985) Night-time sleep EEG changes following body heating in a warm bath. Electroencephalogr Clin Neurophysiol 60:154–157

    Article  PubMed  CAS  Google Scholar 

  • Houghton G, Dennis M, Templeton R, Martin B (1985) A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone. Int J Clin Pharmacol Ther Toxicol 23:97–100

    PubMed  CAS  Google Scholar 

  • Hudson JJ, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ (1988) Electroencephalo-graphic sleep in mania. Arch Gen Psychiat 45(3):267–273

    Article  PubMed  CAS  Google Scholar 

  • Idzikowski C, Mills FJ, James RJ (1991) A dose-response study examining the effects of ritanserin on human slow wave sleep. Br J Clin Pharmacol 31(2): 193–196

    PubMed  CAS  Google Scholar 

  • Idzikowski C, Mills FJ, Glenhard R (1986) 5-Hydroxytryptamine-2-antagonist increases human slow wave sleep. Brain Res 378:164–168

    Article  PubMed  CAS  Google Scholar 

  • Idzikowski C, Cowen PJ, Nutt D, Mills FJ (1987) The effect of chronic ritanserin treatment on sleep and the neuroendocrine response to L-Tryptophan. Psychopharmacology 93:416–420

    Article  PubMed  CAS  Google Scholar 

  • Insel TR, Gillin JC, Moore A et al. (1982) The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 39:1372–1377

    Article  PubMed  CAS  Google Scholar 

  • Institute of Medicine (ed) (1979) Sleeping pills, insomnia and medical practice: report of a study. Nat Acad Sci, Washington, Inst Med Publ 79-04

    Google Scholar 

  • Jacobs EA, Reynolds II CF, Kupfer DJ et al. (1988) The role of polysomnography in the differential diagnosis of chronic insomnia. Annu J Psychiat 154:346–349

    Google Scholar 

  • Jacobson E (1938) Progressive relaxation. Univ Press, Chicago

    Google Scholar 

  • James SP, Sack DA, Rosenthal NE, Mendelson WB (1990) Melatonin administration in insomnia. Neuropsychopharmacology 3:19–23

    PubMed  CAS  Google Scholar 

  • Johnson LC, Chernik DA (1982) Sedative hypnotics and human performance. Psychopharmacology 76:101–113

    Article  PubMed  CAS  Google Scholar 

  • Jouvet M (1984) Indolamines and sleep-inducing factors. In: Borbely AA, Valat JL (eds) Exp Brain Res Suppl 8:84–94

    Google Scholar 

  • Jovanovic UJ, Dreyfus JF (1983) Polygraphic sleep recordings in insomniac patients under zopiclone or nitrazepam. Pharmacology 27:136–145

    Article  PubMed  Google Scholar 

  • Judd LL, Mc Adams LA, Ellinwood E (1987) Cognitive performance and mood in patients with chronic insomnia during short-and long-term administration of two benzodiazepines, fluraze-pam and midazolam. Sleep Res 16:97

    Google Scholar 

  • Julou L, Blanchard JC, Dreyfus JF (1985) Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav 23:653–659

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Kales JD (1984) Evaluation and treatment of insomnia. Oxford Univ Press, New York

    Google Scholar 

  • Kales A, Scharf MB (1978) Rebound insomnia: a new clinical snydrome. Science 201:1039–1041

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Kales JD, Soldatos CR (1982) Insomnia and other sleep disorders. Med Clin N Am 66(5):971–991

    PubMed  CAS  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Kales JD (1983a) Rebound insomnia and rebound anxiety: a review. Pharmacology 26:121–137

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Kales JD (1983b) Early morning insomnia with rapidly eliminated benzodiazepines. Science 220:95–97

    Article  PubMed  CAS  Google Scholar 

  • Kanfer FM, Goldstein AP (1977) Möglichkeiten der Verhaltensänderung. Urban & Schwarzenberg, München

    Google Scholar 

  • Karacan I, Thornby JI, Anch M et al. (1976) Prevalence of sleep disturbance in a primarily urban Florida county. Soc Sci Med 10:239–244

    Article  PubMed  CAS  Google Scholar 

  • Karasu TB (1978) Psychotherapy with the somatically ill patient. In: Karasu TB, Steinmüller RI (eds) Psychotherapeutics in medicine. Grune & Stratton, New York

    Google Scholar 

  • Kielholz (1971) Diagnose und Therapie der Depression für den Praktiker. Lehmann, München

    Google Scholar 

  • Killen J, Coates TJ (1984) The complaint of insomnia: what is it and how do we treat? Franks CM (ed) New developments in behavior therapy: from research to clinical application. Haworth, New York, pp 377–408

    Google Scholar 

  • King C (1981) Effects of beta-endorphin and morphine on the sleep-wakefulness behavior of cats. Sleep 4:259–262

    PubMed  CAS  Google Scholar 

  • Klimm HD, Dreyfus JF, Delmotte M (1987) Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 10:73–78

    PubMed  Google Scholar 

  • Klotz U (1987) Klinische Pharmakologie der Schlafmittel. In: Hippius H, Rüther E, Schmauß M (Hrsg) Schlaf-Wach-Funktionen. Springer, Berlin Heidelberg New York, pp 145–150

    Google Scholar 

  • Knab B (1989) Schlafstörungen. Kohlhammer, München

    Google Scholar 

  • Körner E, Flooh BE, Reinhart B et al. (1986) Sleep-inducing effect of L-Tryptophan. Eur Neurol 25, Suppl 2:75–81

    PubMed  Google Scholar 

  • Kramer C (1967) Methaqualone and chloral hydrate: preliminary comparison in geriatric patients. J Am Geriatr Soc 15:455–461

    PubMed  CAS  Google Scholar 

  • Krueger JM, Bacsik J, Garcia-Arraras J (1980) Sleep-promoting material from human urine and its relation to factor S from brain. Am J Physiol 238:E116–E126

    PubMed  CAS  Google Scholar 

  • Krueger JM, Walter J, Dinarello CA et al. (1984) Sleep promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 246:994–999

    Google Scholar 

  • Kubicki ST, Engfer A (1988) Schlaf-und Schlafmittelforschung. Vieweg, Braunschweig Wiesbaden

    Google Scholar 

  • Kuitunen T, Mattila MJ, Seppala T (1990) Actions and interactions of hypnotics on human performance: single does of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol 5(2):115–130

    PubMed  Google Scholar 

  • Kupfer D (1982) Interaction of EEG sleep, antidepressants and affective disease. J Clin Psychiat 43:30–35

    CAS  Google Scholar 

  • Lacks P, Bertelson AD, Gans L, Kunkel J (1983a) The effectiveness of three behavioral treatments for different degrees of sleep-onset insomnia. Behav Ther 14:593–605

    Article  Google Scholar 

  • Lacks P, Bertelson AD, Sugerman J, Kunkel J (1983b) The treatment of sleep-maintenance insomnia with stimulus-control techniques. Behav Res Ther 21(3):291–295

    Article  PubMed  CAS  Google Scholar 

  • Lader M, Denney SC (1983) A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers. Pharmacology 27:98–108

    Article  PubMed  Google Scholar 

  • Lader M, Petursson (1983) Rational use of anxiolytic/sedative drugs. Drugs 25:514–528

    Article  PubMed  CAS  Google Scholar 

  • Ladouceur R, Gros-Louis Y (1986) Paradoxical intention vs stimulus control in the treatment of severe insomnia. J Behav Ther Exp Psychiat 17(4):267–269

    Article  CAS  Google Scholar 

  • Langer SZ, Arbilla S, Scatton B, Niddam R, Dubois A (1988) Receptors involved in the mechanism of action of Zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 55–70

    Google Scholar 

  • Laux G, König W (1986) Langzeiteinnahme und Abhängigkeit von Benzodiazepinen. Ergebnisse einer epidemiologischen Studie. In: Hippius H, Engel RR, Laakmann G (Hrsg) Benzodiazepine. Rückblick und Ausblick. Springer, Berlin Heidelberg New York, S 226–233

    Google Scholar 

  • Leathwood PD, Chauffard F, Heck E, Munoz-Box R (1982) Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17:65–71

    Article  PubMed  CAS  Google Scholar 

  • Leutner V (1990) Schlaf, Schlafstörung, Schlafmittel. Edn Roche, Basel

    Google Scholar 

  • Levy AB, Dixon KN, Schmidt H (1988) Sleep architecture in anorexia nervosa and bulimia. Biol Psychiat 23(1):99–101

    Article  PubMed  CAS  Google Scholar 

  • Liebermann HR (1986) Behavior, sleep and melatonin. J Neural Transm Suppl 21:233–241

    Google Scholar 

  • Lindemann H (1975) Überleben im Streß. Autogenes Training. Mosaik, München

    Google Scholar 

  • Linkowski P, Kerkhofs M, Rielaert C, Mendlewicz J (1986) Sleep during mania in manic-depressive males. Eur Arch Psychiat Neurol Sci 235(6):339–341

    Article  CAS  Google Scholar 

  • Livingston RL, Zucker DK, Isenberg K, Wetzel RD (1983) Tricyclic antidepressants and delirium. J Clin Psychiat 44:173–176

    CAS  Google Scholar 

  • Louvel E, Cramer P, Ferreri M, Pagot R, Regnier F, L’Heritier Ch, Orofiamma B (1988) Zolpidem and Triazolam: long-term multicenter studies (1–3 months) in psychiatric and general practice patients. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 327–337

    Google Scholar 

  • Lugaresi E, Zucconi M, Bixler EO (1987) Epidemiology of sleep disorders. Psychiat Ann 17:446–453

    Google Scholar 

  • Lumley M, Roehrs T, Asher D, Zorick F, Roth T (1987) Ethanol and coffein effects on daytime sleepiness/alertness. Sleep 10:306–312

    PubMed  CAS  Google Scholar 

  • Lund R, Rüther E (1984) Medikamentöse Behandlung von Schlafstörungen. Internist 25:543–546

    PubMed  CAS  Google Scholar 

  • Lund R, Rüther E (1985) Chronische Hyposomnie. In: Faust V (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 76–83

    Google Scholar 

  • Lund R, Rüther E, Wober W, Hippius H (1988) Effects of Zolpidem (10 and 20 mg), Lormetazepam, Triazolam and Placebo on night sleep and residual effects during the day. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 193–203

    Google Scholar 

  • Maillard F, Autret E, Autret A (1984) Effects of zopiclone as compared to triazolam on adult insomniacs. In: 7th Eur Sleep Congr, München, 5.9.1984

    Google Scholar 

  • Maisch U (1987) Behandlung von Schlafstörungen bei älteren Patienten. Therapiewoche 37:2484–2487

    Google Scholar 

  • Mamelak M, Scima A, Price V (1983) Effects of zopiclone on the sleep of chronic insomniacs. Pharmacol 27:136–145

    Article  Google Scholar 

  • Mamelak M, Csima A, Price B (1984) A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs. J Clin Pharmacol 24:65–75

    PubMed  CAS  Google Scholar 

  • Mansbach RS, Lorenz DN (1983) Cholecystokinin (CCK-8) elicits prandial sleep in rats. Physiol Behav 30:179–183

    Article  PubMed  CAS  Google Scholar 

  • Maritila J, Hammel R, Alexander B, Zustiak R (1977) Potential untoward effects of long-term use flurazepam in geriatric patients. J Am Pharm Assoc 17:692–695

    Google Scholar 

  • Meichenbaum DC (1979) Cognitive-behavior modification: an integrative approach. Plenum, New York

    Google Scholar 

  • Meier-Ewert K (1989) Tagesschläfrigkeit. Edition Medizin. VCH, Weinheim

    Google Scholar 

  • Mellinger GD, Balter MB, Uhlenhut EH (1985) Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiat 42:225–232

    Article  PubMed  CAS  Google Scholar 

  • Mendelson WB (1980) The use and misuse of sleeping pills. A clinical guide. Plenum, New York

    Google Scholar 

  • Mendelson WB (1987a) Human sleep: research and clinical care. Plenum, New York

    Google Scholar 

  • Mendelson WB (1987b) Pharmacotherapy of insomnia. Psychat Clin N Am 10(4):555–563

    CAS  Google Scholar 

  • Mendelson WB (1990) Hypnotics in the treatment of chronic insomnia. In: Thorpy MJ (ed) Handbook of sleep disorders. Dekker, New York Basel, pp 737–754

    Google Scholar 

  • Mendelson WB, Gillin JC, Pisner G, Wyatt RJ (1980) Arginine vasotocin and sleep in the rat. Brain Res 182:246–249

    Article  PubMed  CAS  Google Scholar 

  • Mendelson WB, Wyatt RJ, Gillin JC (1983) Whiter the sleep factors? In: Chase MH, Weitzman ED (eds) Sleep disorders: basic and clinical research. MTP, Lancaster, pp 281–305

    Google Scholar 

  • Mendelson WB, Garnett D, Gillin JC, Weingartner H (1984a) The experience of insomnia and daytime and nighttime functioning. Psychiat Res 12(3):235–250

    Article  CAS  Google Scholar 

  • Mendelson WB, Garnett D, Linnoila M (1984b) Do insomniacs have impaired daytime functioning? Biol Psychiat 19(8):1261–1264

    PubMed  CAS  Google Scholar 

  • Merlotti L, Roehrs F, Zorick E et al. (1988) Rebound insomnia, duration of administration, and individual differences. Sleep Res 17:52

    Google Scholar 

  • Miles LE, Dement WC (1980) Objective sleep parameters in elderly men and women. Sleep 3(2):131–151

    Google Scholar 

  • Mirmian M, Pevet P (1986) Effect of melatonin and methoxtryptamine on sleep-wake-patterns in the male rat. J Pineal Res 3:135–141

    Article  Google Scholar 

  • MMWR (ed) (1989) Update: Eosinophilia — myalgia syndrome associated with the ingestion of L-Tryptophan. US Morbid Mortal Week Rep 38(48):842–843

    Google Scholar 

  • Momose T (1983) Effectiveness of zopiclone as a preoperative hypnotic. Pharmacology 27:196–204

    Article  PubMed  Google Scholar 

  • Monti JM, Debellis J, Alterwain P et al. (1987) Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. Int J Pharmacol Res 7:105–110

    CAS  Google Scholar 

  • Moon CAL, Ankier SI, Hayes G (1985) Early morning insomnia and daytime anxiety — a multicentre general practice study comparing Loprazolam and Triazolam. Br J Clin Practice 39(9):352–358

    CAS  Google Scholar 

  • Moran MG, Thompson TL, Nies AS (1988) Sleep disorders in the elderly. Am J Psychiat 145:1369–1378

    PubMed  CAS  Google Scholar 

  • Morgan K (1984) Effects of two benzodiazepines on the speed and accuracy of perceptual-motor performance in the elderly. Psychopharmacol Suppl 1:79–83

    Google Scholar 

  • Morgan K, Oswald I (1982) Anxiety caused by a short life hypnotic. Br Med J 284:942

    Article  CAS  Google Scholar 

  • Morin CM, Kwentus JA (1990) Behavioral and pharmacological treatments for insomnia. Am Behav Med 10:91–110

    Article  Google Scholar 

  • Morris III HH, Estes ML (1987) Traveler’s amnesia: transient global amnesia secondary to triazolam. JAMA 258:945–946

    Article  PubMed  Google Scholar 

  • Morselli PL (eds) (1988) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 193–203

    Google Scholar 

  • Morselli PL, Larribaud J, Guillet Ph, Thiercelin JF, Barthelet G, Grilliat JP, Thebault JJ (1988) Daytime residual effects of Zolpidem: a review of available data. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 183–203

    Google Scholar 

  • Mossberg D, Liljeberg P, Borg S (1985) Clinical conditions in alcoholics during long-term abstinence: a descriptive longitudinal treatment study. Alcohol 2:551–553

    Article  PubMed  CAS  Google Scholar 

  • Müller-Limmroth W, Ehrenstein M (1977) Untersuchungen über die Wirkung von Seda Kneipp auf den Schlaf schlafgestörter Menschen. Med Clin 25:1119–1125

    Google Scholar 

  • Muraoka H, Ischii N, Yamada K et al. (1987) Sleep disorders of alcoholics. Sleep Res 16:493

    Google Scholar 

  • Murphy JE, Ankier SI (1984) A comparison of hypnotic activity of loprazolam, flurazepam and placebo. Br J Clin Practice 38:141–149

    CAS  Google Scholar 

  • Mutschler E (1986) Arzneimittelwirkungen. Wissenschaftliche Verlagsges, Stuttgart, S 162 ff

    Google Scholar 

  • Nedopil N, Rüther E (1984) Medikamentöse Therapie von Schlafstörungen. Münchener Med Wo-chenschr 126:290–291

    Google Scholar 

  • Nicassio PM, Bootzin R (1974) A comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol 83:253–260

    Article  PubMed  CAS  Google Scholar 

  • Nicassio PM, Buchanan DC (1981) Clinical application of behavior therapy for insomnia. Comprehens Psychiat 22:512–521

    Article  CAS  Google Scholar 

  • Nicassio PM, Pate JK, Mundlowitz DR, Woosward N (1985) Insomnia: nonpharmacologic management by private practice physicians. South Med J 78:556–560

    Article  PubMed  CAS  Google Scholar 

  • Nicholson AN (1983) Antihistamines and sedation. Lancet 2:211–212

    Article  PubMed  CAS  Google Scholar 

  • Nicholson AN, Pascoe PA (1988) Hypnotic activity of Zolpidem: night-time and daytime studies in young and middle-aged adults. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 231–240

    Google Scholar 

  • Nicholson AN, Pascoe PA (1986) Hypnotic activity of an Imidazopyridine (Zolpidem). Br J Clin Pharmac 21:205–211

    CAS  Google Scholar 

  • Nicholson AN, Stone BM, Pascoe P (1982) Hypnotic efficacy in middleage. J Clin Psychopharmacol 2:118–121

    Article  PubMed  CAS  Google Scholar 

  • NIMH — National Institute of Mental Health (1984) Concensus conference report: drugs and insomnia — the use of medications to promote sleep. JAMA 251:2410–2414

    Article  Google Scholar 

  • Normanton JR, Gent JP (1983) Comparison of the effects of two „sleep“ peptides, delta-sleep-inducing peptide and arginine-vasotonin, on single neurons in the rat and rabbit brain stem. Neuroscience 8:107–114

    Article  PubMed  CAS  Google Scholar 

  • O’Hanlon JF, Volkerts ER (1986) Hypnotics and actual driving performance. Act Psychiat Scand Suppl 332 vol 74:95–104

    Article  Google Scholar 

  • Oswald I, Adam K (1988) A new look at short-acting hypnotics. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 253–259

    Google Scholar 

  • Oswald I, Adam K, Borrow S, Idzikowski C (1979) The effects of two hypnotics on sleep, subjective feelings and skilled performance. In: Passouant P, Oswald I (eds) Pharmacology of states of alertness. Pergamon, Oxford, pp 51–63

    Google Scholar 

  • Othmer E, Danghady WH, Goodwin DW et al. (1982) Sleep and the growth hormone secretion in alcoholics. J Clin Psychiat 43:411–414

    CAS  Google Scholar 

  • O’Toole DP, Carlisle RJT, Howard PJ, Dundee JW (1986) Effects of altered gastric motility on the pharmacokinetics of orally administered zopiclone. Ir J Med Sci 155:136

    Google Scholar 

  • Owen RT, Tyrer P (1983) Benzodiazepine dependence. A review of the evidence. Drugs 25:385–398

    Article  PubMed  CAS  Google Scholar 

  • Palminteri R, Narbonne G (1988) Safety profile of Zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 351–361

    Google Scholar 

  • Pappenheimer JR (1982) Sleep factor in CSF, brain and urine. Front Hormone Res 9:173–178

    CAS  Google Scholar 

  • Parkes JD (1985) Sleep and its disorders. Saunders, Eastbourne

    Google Scholar 

  • Partinen M, Eskelinen L, Tuomi K (1984) Complaints of insomnia in different occupations. Scand J Work Environ Health 10:467–469

    Article  PubMed  CAS  Google Scholar 

  • Paton DM, Webster DR (1985) Clinical pharmcokinetics of H1-receptor antagonists (the antihistamines). Clin Pharmacokinet 10:477–497

    Article  PubMed  CAS  Google Scholar 

  • Pecknold J, Wilson R, Le Morvan P (1990) Long term efficacy and withdrawal of zopiclone, a sleep laboratory study. Int Clin Psychopharmacol 5(2):57–67

    PubMed  Google Scholar 

  • Pena de la A (1978) Toward a psychophysiologic conceptualization of insomnia. In: Williams RL, Karacan I (eds) Sleep disorders, diagnosis and treatment. John Wiley & Sons, New York, pp 101–144

    Google Scholar 

  • Pharmaceutical Journal (1991) CSM comments on zopiclone dependence. Pharm 1:78

    Google Scholar 

  • Philipp M, Buller R (1986) Klassifikatorische Probleme von Mißbrauch und körperlicher Abhängigkeit bei Benzodiazepinen. In: Hippius H, Engel RR, Laakmann G (Hrsg) Benzodiazepine. Rückblick und Ausblick. Springer, Berlin Heidelberg New York, S 234–241

    Google Scholar 

  • Piel E (1985) Schlafschwierigkeiten und soziale Persönlichkeit. Einige sozialempirische Daten. In: Faust V (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 14–26

    Google Scholar 

  • Pokorny AD (1978) Sleep disturbances, alcohol, and alcoholism: a review. In: Williams RL, Karacan I (eds) Sleep disorders: diagnosis and treatment. John Wiley & Sons, New York, pp 233–260

    Google Scholar 

  • Pöldinger W, Wider F (1985) Tranquilizer and Hypnotika. Fischer, Stuttgart

    Google Scholar 

  • Ponciano E, Freitas F, Camara J et al. (1990) A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. Int Clin Psychopharmacol 5(2):69–77

    PubMed  Google Scholar 

  • Poser W (1991) Entstehung und Verlauf von Benzodiazepin-Abhängigkeiten. Z Allgemeinmed 15:935–939

    Google Scholar 

  • Puder R, Lacks P, Bertelson AD, Storandt M (1983) Short term stimulus control treatment of insomnia in older adults. Behav Ther 14:424–429

    Article  Google Scholar 

  • Pull CB, Dreyfus JF, Brun JP (1983) Comparison of nitrazepam and zopiclone in psychiatric patients. Pharmacology 27(2):205–209

    Article  PubMed  Google Scholar 

  • Quadens OP, Hoffman G, Buytaert G (1983) Effects of zopiclone as compared to flurazepam in women over 40 years of age. Pharmacology 27:146–155

    Article  PubMed  Google Scholar 

  • Rapaport J, Elkins R, Langer D et al. (1981) Childhood obsessive compulsive disorder. Am J Psychiat 138:1545–1554

    Google Scholar 

  • Reeves R (1977) Comparison of triazolam, flurazepam and placebo as hypnotics in geriatric patients with insomnia. J Clin Pharmacol 17:319–323

    PubMed  CAS  Google Scholar 

  • Reiter RJ (1986) Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transmitt Suppl 21:35–54

    CAS  Google Scholar 

  • Reynolds CF (1989) Sleep in affective disorders. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 413–416

    Google Scholar 

  • Reynolds CF, Kupfer DJ (1987) Sleep research in affective illness: state of the art circa 1987. Sleep 10(3):199–215

    PubMed  Google Scholar 

  • Rickels K, Morris RJ, Newman H et al. (1983) Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 23:235–242

    Google Scholar 

  • Rickels K, Ginsberg J, Morris RJ (1984) Doxylamine succinate in insomniac family practice patients: a double blind study. Curr Ther Res 35:532–540

    Google Scholar 

  • Roehrs T, Zorick F, Kaffeemann M et al. (1982) Flurazepam for short-term treatment of complaints of insomnia. J Clin Pharmacol 22:290–296

    PubMed  CAS  Google Scholar 

  • Roehrs TA, Zorick FJ, Wittig RM, Roth T (1986) Dose determinants of rebound insomnia. Br J Clin Pharmacol 22(2): 143–147

    PubMed  CAS  Google Scholar 

  • Roger M et al. (1991) Efficacy of Zolpidem 5 and 10 mg in elderly. A double blind study versus triazolam 0.25 mg. Biol Psychiatry, Suppl:689

    Google Scholar 

  • Rojas-Ramirez JA, Crawley JN, Mendelson WB (1982) Electroencephalographic analysis of the sleep-inducing action of cholecystokinin. Neuropeptides 3:129–138

    Article  PubMed  CAS  Google Scholar 

  • Rote Liste (1991) Bundesverband der Pharmazeutischen Industrie e.V., Frankfurt/Main

    Google Scholar 

  • Rudestam KE (1980) Methods of self-change. Brooks/Cole, Monterey, Cal

    Google Scholar 

  • Rudolf GA (1985) Der Schlaf bei endogenen Psychosen. In: Faust (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 94–100

    Google Scholar 

  • Rudolf GA (1990) Der Stellenwert der in der Behandlung von Schlafstörungen verwendeten Hypnotika. In Rudolf GA, Engfer A (Hrsg) Schlafstörungen in der Praxis. Diagnostische und therapeutische Aspekte. Vieweg, Braunschweig Wiesbaden, S 48–61

    Google Scholar 

  • Rüther E (1984) Wann Schlafmittel? Arzneiverord Praxis 5:49–53

    Google Scholar 

  • Rüther E (1986) Benzodiazepine zur Behandlung von Schlafstörungen. In: Hippius H, Engel RR, Laakmann G (Hrsg) Benzodiazepine. Springer, Berlin Heidelberg New York, S 101–107

    Chapter  Google Scholar 

  • Rüther E, Engfer A (1988) Schlafstörungen: Häufigkeit — Ursachen — medikamentöse Behandlung. In: Kubicki ST, Engfer A (Hrsg) Schlaf-und Schlafmittelforschung. Neue Ergebnisse und therapeutische Konsequenzen. Vieweg, Braunschweig Wiesbaden, S 9–20

    Google Scholar 

  • Rüther E, Hajak G (1992) Depression with sleep disturbances. In: Freeman HL (ed) The uses of fluoxetine in clinical practice Royal Society of Medicines Services, London, pp 27–34

    Google Scholar 

  • Scharf MB, Hirschowitz J, Zemlon FP, Lichstein M, Wood M (1986) Comparative effects of Limb-itrol and Amitriptylin on sleep efficiency and architecture. J Clin Psychiat 47:587–591

    CAS  Google Scholar 

  • Scharf MB, Fletcher K, Graham JP (1988) Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiat 49:134–137

    CAS  Google Scholar 

  • Schimmel KCH (1985) Pflanzliche Sedativa. In: Faust V (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 188–194

    Google Scholar 

  • Schindler L, Hohenberger E (1985) Verhaltenstherapie als Alternative zur Behandlung von Schlafstörungen. In: Faust V (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 137–143

    Google Scholar 

  • Schlich D et al. (1991) Long-term treatment of insomnia with Zolpidem: a multicentre general practitioner study of 107 patients. J Int Med Res 19:271–279

    PubMed  CAS  Google Scholar 

  • Schmidt LG (1990) Mißbrauch und Abhängigkeit von Schlafmitteln. In: Rudolf GA, Engfer A (Hrsg) Schlafstörungen in der Praxis. Diagnostische und therapeutische Aspekte. Vieweg, Braunschweig Wiesbaden, S 65–78

    Google Scholar 

  • Schneider-Helmert D (1985) Klassifikation und Differentialdiagnose der verschiedenen Schlafstörungen. In: Faust V (Hrsg) Schlafstörungen. Hippokrates, Stuttgart, S 9–13

    Google Scholar 

  • Schneider-Helmert D (1988) DSIP: clinical application of the programming effect. In: Inoue S, Schneider-Helmert D (eds) Sleep peptides: basic and clinical approaches. Jpn Sci Soc Press, Tokyo, pp 175–198

    Google Scholar 

  • Schneider-Helmert D, Spinweber CL (1986) Evaluation of L-Tryptophan for treatment of insomnia. Psychopharmacology 89:1–7

    Article  PubMed  CAS  Google Scholar 

  • Schubert FC (1986) Kognitive Therapie psychogener Schlafstörungen: Ein Erklärungs-und Handlungsansatz. Psychiat Prax 13(1):1–9

    CAS  Google Scholar 

  • Schulz H, Jobert M, Jähnig P (1991) Macro-and microstructure of sleep in insomniac patients under the influence of a benzodiazepine and a nonbenzodiazepine hypnotic. In: Racagni G, Brunello N, Fukuda T (eds) Biological psychiatry, vol 1. Elsevier, Amsterdam, pp 823–826

    Google Scholar 

  • Settle EC, Ayd FJ (1980) Trimipramine: twenty years worldwide clinical experience. J Clin Psychiat 41:266–274

    Google Scholar 

  • Seyffart G (1983) Chloral hydrate and related drugs. In: Haddad LM, Winchester JF (eds) Clinical management poisoning and drug overdose. Saunders, Philadelphia, pp 527–531

    Google Scholar 

  • Shapiro CM, Warren PM, Trinder J et al. (1984) Fitness facilitates sleep. Eur J Appl Physiol 53:1–4

    Article  CAS  Google Scholar 

  • Sieb JP, Clarenbach P (1990) Anterograde Amnesie unter Benzodiazepin-Hypnotika. In: Meier-Ewert K (Hrsg) Schlaf und Schlafstörungen. Springer, Berlin Heidelberg New York, S 156–164

    Google Scholar 

  • Soldates CR, Kales A, Kales JD (1979) Management of insomnia. Annu Rev Med 30:301–312

    Article  Google Scholar 

  • Soldates CR, Kales JD, Tjiauw-Ling T, Kales A (1987) Classification of sleep disorders. Psychiat Ann 17:454–458

    Google Scholar 

  • Spiegel R, Allen SR (1984) Die Wirkung eines nicht rezeptpflichtigen Schlafmittels auf das Schlafpolygramm gesunder Probleme. Schweiz Rundsch Med (Prax) 73:163–173

    Google Scholar 

  • Spiegel R, Köberle S, Allen Sr (1986) Significance of slow wave sleep: considerations from a clinical viewpoint. Sleep 9(1):66–79

    PubMed  CAS  Google Scholar 

  • Spielman AJ, Saskin P, Thorpy MJ (1983) Sleep restriction treatment of insomnia. Sleep Res 12:286

    Google Scholar 

  • Spielman AJ, Saskin P, Thorpy MJ (1984) Sleep restriction therapy for chronic insomnia. Outcome as a function of pre-treatment total sleep time. Sleep Res 13:167

    Google Scholar 

  • Spielman AJ, Caruso LS, Glovinsky PB (1987) A behavioral perspective on insomnia treatment. Psychiat Clin N Am 10(4):541–553

    CAS  Google Scholar 

  • Spinweber CL, Johnson LC (1982) Effects of triazolam (0,5 mg) on sleep, performance memory and arousal threshold. Psychopharmacology 76:5–12

    Article  PubMed  CAS  Google Scholar 

  • Steinberg R (1989) Behandlung chronischer Schlafstörungen in der Praxis. In: Hippius H, Lauter H, Greil W (Hrsg) Psychiatrie für die Praxis 10. Der gestörte Schlaf. MMW, München, S 57–70

    Google Scholar 

  • Steinberg R, Hippius H, Nedopil N, Rüther E (1984a) Aspekte der modernen Schlafforschung. Nervenarzt 55(9):461–470

    PubMed  CAS  Google Scholar 

  • Steinberg R, Einhäupl K, Hippius H et al. (1984b) Chronische Hyposomnien in einer Schlafam-bulanz. Nervenarzt 55(9):471–476

    PubMed  CAS  Google Scholar 

  • Steinberg R, Brenner PM, Lund R, Rüther E (1987) Behandlung chronischer Insomnien. In: Hippius H, Rüther E, Schmauß H (Hrsg) Schlaf-Wach-Funktionen. Springer, Berlin Heidelberg New York, S 131–143

    Google Scholar 

  • Steinmark SW, Borkovec TD (1954) Active and placebo treatments effects on moderate insomnia and positive demand instructions. J Abnorm Psychol 83:157–163

    Article  Google Scholar 

  • Sussmann N (1988) Anxiety disorders. Psychiat Ann 18:134–189

    Google Scholar 

  • Tamminen T, Ahokallio A, Aropuu R et al. (1983) Zoplicone and nitrazepam in the treatment of chronic insomnia. In: 7th World Congr Psychiatry. Wien, 11.–16. Juli 1983

    Google Scholar 

  • Tan TL, Kales JD, Kales A et al. (1984) Biopsychobehavioral correlates of insomnia IV. Diagnosis based on DSM-III. Am J Psychiat 141:357–363

    PubMed  CAS  Google Scholar 

  • Thenot JP, Hermann P, Durand A, Burke JT, Allen J, Garrigou D, Vajta S, Albin H, Thebault JJ, Olive G, Warrington SJ (1988) Pharmacokinetics and metabolism of Zolpidem in various animal species and in humans. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. L.E.R.S. monograph series, v 6. Raven, New York, pp 139–153

    Google Scholar 

  • Thoresen CE, Coates TJ, Kirmil-Gray K, Rosekind MR (1981b) Behavioral self-management in treating sleep-maintenance insomnia. J Behav Med 4:41–53

    Article  PubMed  CAS  Google Scholar 

  • Thorpy MJ (1990) Disorders of arousal. In: Thorpy MJ (ed) Handbook of sleep disorders. Dekker, New York, pp 531–549

    Google Scholar 

  • Tobler I, Borbely AA, Schwyzer M, Fontana A (1984) Interleukin-1 derived from astrocytes in-hances slow wave activity in sleep EEG of the rat. Eur J Pharmacol 104:191–192

    Article  PubMed  CAS  Google Scholar 

  • Trachsel L, Dijk DD, Brunner DP et al. (1990) Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology 3:11–18

    PubMed  CAS  Google Scholar 

  • Trifiletti RR, Snyder SH (1984) Anxiolytic cyclopyrroles zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepines. Mol Pharmacol 26:458–469

    PubMed  CAS  Google Scholar 

  • Ueno R, Ishikawa Y, Nakayama T, Hayaishi O (1982) Prostaglandin D2 induces sleep when mi-croinjected into the preoptic area of conscious rats. Biochem Biophys Res Commun 109:576–582

    Article  PubMed  CAS  Google Scholar 

  • Vollrath L, Seem P, Gammel G (1981) Sleep induction by intranasal application of melatonin. Bioscience 29:327–329

    Google Scholar 

  • Wagner DR (1990) Circadian rhythm sleep disorders. In: Thorpy MJ (ed) Handbook of sleep disorders. Dekker, New York Basel, pp 493–527

    Google Scholar 

  • Waldhauser F, Saletu B, Trinchard-Lugan I (1990) Sleep laboratory investigation of hypnotic properties of melatonin. Psychopharmacology 100:222–226

    Article  PubMed  CAS  Google Scholar 

  • Walsh BT, Goetz R, Roose SP et al. (1985) EEG monitored sleep in anorexia nervosa and bulimia. Biol Psychiat 20(9):947–956

    Article  PubMed  CAS  Google Scholar 

  • Ware JC (1983) Tricyclic antidepressants in the treatment of insomnia. J Clin Psychiat 44:25–28

    CAS  Google Scholar 

  • Wheathley D (1985) Zopiclone: a non-benzodiazepine hypnotic controlled comparison to temaze-pam in insomnia. Br J Psychiat 146:312–314

    Article  Google Scholar 

  • WHO Center for Classification of Diseases for North America (1978) International classification of diseases, 9th revision. Clinical modification (ICD-9-CM). National center for health statistics. Edward, Ann Harbour

    Google Scholar 

  • Wickstrom E, Giercksky K-E (1980) Comparative study of zopiclone, a novel hypnotic, and three benzodiazepines. Eur J Clin Pharmacol 17:93–99

    Article  PubMed  CAS  Google Scholar 

  • Wickström E, Barbo SE, Dreyfus JF et al. (1983) A comparative study of zopiclone and flunitraze-pam in insomniacs seen by general practioners. Pharmacology 27:165–172

    Article  PubMed  Google Scholar 

  • Wiegand M, Berger M, Zulley J, von Zerssen D (1986) The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 19:198–199

    Article  CAS  Google Scholar 

  • Williams DL, MacLean AW, Cairns J (1983) Dose-response effects of ethanol on the sleep of young woman. J Stud Alcohol 44:515–523

    PubMed  CAS  Google Scholar 

  • Willumeit HP, Ott H, Neubert W (1984) Stimulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short and long-acting benzodiazepines. In: Hindmarch J, Ott H, Roth T (eds) Sleep, benzodiazepine, and performance. Springer, Berlin Heidelberg New York, pp 182–192

    Google Scholar 

  • Wilson CM, Robinson FP, Thompson EM et al. (1986) Effect of pretreatment with ranitidine on the hypnotic action of single dose of midazolam, temazepam and zopiclone. Br J Anaesth 58:483–486

    Article  PubMed  CAS  Google Scholar 

  • Wolf B, Rüther E (1984) Benzodiazepinabhängigkeit. Münchener Med Wochenschr 126:294–296

    Google Scholar 

  • Zarcone V (1989) Sleep abnormalities in schizophrenia. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 422–423

    Google Scholar 

  • Zwart CA, Lisman SA (1979) Analysis of stimulus control treatment of sleep-onset insomnia. J Consult Clin Psychol 47:113–118

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Hajak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Herrendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Rüther
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pathologische Physiologie, Humboldt-Universität zu Berlin, Ziegelstraße 5-9, O-1040, Berlin, Deutschland

    Karl Hecht  & Marianne Poppei  & 

  2. Schering AG, Pharma Deutschland Medizin, Postfach 65 03 11, W-1000, Berlin 65, Deutschland

    Adalbert Engfer

  3. Zentrum für Innere Medizin, Medizinische Poliklinik, Baldingerstraße, W-3550, Marburg, Deutschland

    Jörg Herrmann Peter

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Hajak, G., Herrendorf, G., Rüther, E. (1993). Therapie von Insomnien. In: Hecht, K., Engfer, A., Peter, J.H., Poppei, M. (eds) Schlaf, Gesundheit, Leistungsfähigkeit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77111-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77111-8_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54843-0

  • Online ISBN: 978-3-642-77111-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation